Literature DB >> 7101335

[Long term results of radiotherapy of degenerative joint diseases (author's transl)].

H Lindner, R Freislederer.   

Abstract

At the Radiologic Department of The Städtisches Krankenhaus Passau, 473 patients with degenerative diseases in the big joints and the spine were irradiated with the caesium unit between 1971 and 1979. Among these patients, 249 could be followed up during a prolonged period (1/2 to 9 years, i.e. 4.2 years on an average). According to the categories of v. Pannewitz, 11% were pain-free at this moment, 21% showed an essential improvement, 29% showed an improvement, and 39% were not influenced by the treatment. 13.5% showed recurrent pains; these were mentioned as "not influenced" in the statistical analysis. It is proved that the relief of pain does not depend on the age of the patients, but on the anamnesis period, the results of the X-ray examination, and the degree of the restriction of mobility. Due to the delay of irradiation, a preliminary treatment mostly produces a less favorable radiotherapeutic result. Compared with other therapeutic methods, the long term results or radiotherapy of degenerative joint diseases are generally favorable. This conclusion is also confirmed by the results of patients checked up more than five years after the treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7101335

Source DB:  PubMed          Journal:  Strahlentherapie        ISSN: 0039-2073


  13 in total

1.  [Radiotherapy of osteoarthritis. Indication, technique and clinical results].

Authors:  R Ruppert; M H Seegenschmiedt; R Sauer
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

Review 2.  The efficacy and safety of low-dose radiotherapy on pain and functioning in patients with osteoarthritis: a systematic review.

Authors:  M J M Minten; E Mahler; A A den Broeder; J W H Leer; C H van den Ende
Journal:  Rheumatol Int       Date:  2015-08-08       Impact factor: 2.631

3.  Pain on the Plantar Surface of the Foot.

Authors:  Natalia Gutteck; Sebastian Schilde; Karl-Stefan Delank
Journal:  Dtsch Arztebl Int       Date:  2019-02-08       Impact factor: 5.594

4.  Successful treatment of chronic recurrent multifocal osteomyelitis using low-dose radiotherapy : A case report.

Authors:  Christian T Dietzel; Christoph Schäfer; Dirk Vordermark
Journal:  Strahlenther Onkol       Date:  2016-11-07       Impact factor: 3.621

5.  [Epicondylopathia humeri. The indication for, technic and clinical results of radiotherapy].

Authors:  M H Seegenschmiedt; L Keilholz; P Martus; M Kuhr; G Wichmann; R Sauer
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

6.  [Plantar fasciitis and radiotherapy. Clinical and radiobiological treatment results].

Authors:  O Micke; M H Seeegenschmiedt; R Mücke; A de Vries; U Schäfer; N Willich
Journal:  Orthopade       Date:  2005-06       Impact factor: 1.087

7.  Re-irradiation for osteoarthritis-retrospective analysis of 217 joints.

Authors:  Matthias G Hautmann; Philipp Rechner; Matthias Hipp; Ulrich Neumaier; Felix Steger; Fabian Pohl; Markus Weber; Oliver Kölbl; Christoph Süß
Journal:  Strahlenther Onkol       Date:  2019-07-25       Impact factor: 3.621

8.  [Radiotherapy in painful gonarthrosis. Results of a national patterns-of-care study].

Authors:  Ralph Mücke; M Heinrich Seegenschmiedt; Reinhard Heyd; Ulrich Schäfer; Franz-Josef Prott; Michael Glatzel; Oliver Micke
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

9.  Calcifying tendonitis of the shoulder joint : predictive value of pretreatment sonography for the response to low-dose radiotherapy.

Authors:  Boris Adamietz; Rüdiger Schulz-Wendtland; Sedat Alibek; Michael Uder; Rolf Sauer; Oliver Ott; Ludwig Keilholz
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

10.  [Radiotherapy for painful degenerative joint disorders. Indications, technique and clinical results].

Authors:  L Keilholz; H Seegenschmiedt; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-05       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.